Related Experiment Video

Updated: Sep 27, 2026

Magnetic Adjustment of Afterload in Engineered Heart Tissues
09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

[On the mechanisms of cardiac hypertrophy]

D S Pan1, C Tian, L Y Chen

  • 1Fuwai Heart Hospital, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing 100037.

Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|January 21, 2003
PubMed

Insights

Cardiac hypertrophy research highlights energy imbalance as a key driver, influenced by mechanical stress and signaling factors. An unknown small molecule may regulate gene expression and phenotype in this condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Context:

  • Cardiac hypertrophy is a complex cardiac remodeling process.
  • Familial hypertrophic cardiomyopathy and mitochondrial cardiomyopathy are key examples.
  • Understanding the underlying mechanisms is crucial for therapeutic development.

Purpose:

  • To review current research on the mechanisms of cardiac hypertrophy.
  • To discuss the roles of energy supply/demand, mechanical stress, and signaling factors.
  • To propose a hypothesis regarding an unknown regulatory molecule.

Summary:

  • Cardiac hypertrophy is driven by an imbalance between energy supply and demand under pressure overload.
  • Mechanical stress and paracrine/autocrine signaling pathways are implicated in its development.
  • A novel small molecule is hypothesized to regulate gene expression and phenotype in cardiac hypertrophy.

Impact:

  • Provides a comprehensive overview of cardiac hypertrophy mechanisms.
  • Highlights the critical role of energy metabolism in cardiac remodeling.
  • Suggests a new avenue for research into therapeutic targets for cardiac hypertrophy.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...